Treatment of Von Willebrand Disease: Desmopressin

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish
Title of host publicationTextbook of Hemophilia: Second Edition
PublisherWiley-Blackwell
Pages316-319
Number of pages4
ISBN (Print)9781405169141
DOIs
Publication statusPublished - Aug 13 2010

Keywords

  • Desmopressin (DDAVP)
  • Desmopressin treatment - in association with antifibrinolytic amino acids
  • Dual plasma deficiency of von Willebrand factor (VWF) and factor VIII (FVIII)
  • Factor VIII and VWF increase three-to fivefold above baseline values - with desmopressin infused intravenously
  • FVIII assays, tests of choice for monitoring treatment in patients with VWD
  • New nontransfusional treatments of hemophilia and VWD
  • Therapeutic use of desmopressin in VWD
  • Transient headache, facial flushing and mild tachycardia - and frequent side-effects
  • Treatment of von Willebrand disease - desmopressin
  • Use of antifibrinolytic amino acids together with desmopressin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mannucci, P. M. (2010). Treatment of Von Willebrand Disease: Desmopressin. In Textbook of Hemophilia: Second Edition (pp. 316-319). Wiley-Blackwell. https://doi.org/10.1002/9781444318555.ch47